Anika Therapeutics (ANIK) Inventory (2010 - 2026)

Anika Therapeutics (ANIK) has reported Inventory for 17 consecutive years, with $28.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory rose 68.8% year-over-year to $28.6 million in Q2 2026; TTM through Jun 2026 was $28.6 million, a 68.8% increase from a year earlier, with the FY2025 full-year figure at $18.8 million, down 21.09% from the prior year.
• Inventory was $28.6 million for Q2 2026 at Anika Therapeutics, up from $22.8 million in the prior quarter.
• Over five years, Inventory peaked at $51.5 million in Q2 2024 and troughed at $16.3 million in Q3 2025.
• A 5-year average of $32.7 million and a median of $35.3 million in 2022 frame the typical range for Inventory.
• Across the five-year window, Inventory sank 67.12% in 2025 and soared 68.8% in 2026, its largest moves.
• Over 5 years, Inventory stood at $39.8 million in 2022, then slumped by 38.57% to $24.4 million in 2023, then fell by 2.53% to $23.8 million in 2024, then slipped by 21.09% to $18.8 million in 2025, then soared by 52.05% to $28.6 million in 2026.
• The last three Inventory figures came in at $28.6 million (Q2 2026), $22.8 million (Q1 2026), and $18.8 million (Q4 2025), per Business Quant data.